OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022
01 nov. 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, Nov. 01, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2022 after the close of the...
OPKO Health Announces Leadership Changes for BioReference Laboratories
16 août 2022 16h29 HE
|
OPKO Health, Inc.
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his...
OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results
04 août 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, Aug. 04, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2022. Business highlights...
OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022
25 juil. 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, July 25, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2022 after the close of the U.S....
OPKO Health to Present at the 2022 Jefferies Healthcare Conference
02 juin 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, June 02, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 2022 Jefferies Healthcare Conference taking place June 8-10,...
OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results
09 mai 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2022. Business Highlights ...
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
09 mai 2022 09h23 HE
|
OPKO Health, Inc.
Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKODr. Gary Nabel, ModeX President and CEO, former Chief...
OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022
05 mai 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, May 05, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2022 after the close of the U.S....
OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
24 févr. 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, Feb. 24, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2021. Business Highlights ...
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022
17 févr. 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S....